CACNA2D2: Voltage-dependent calcium channel subunit alpha-2/delta-2
The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel.
- Drugs that act on it: 1
- Approved: 0
- In phases 1 to 3: 1
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on CACNA2D2, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 1
| Drug | Furthest stage | Sponsor | Modality | Action | Open trials |
|---|---|---|---|---|---|
| Mirogabalin | Phase 3 | Daiichi Sankyo | Small molecule | ModulatorVoltage-gated calcium channel alpha2/delta subunit 2 modulator | 8 |
| Mirogabalin vs. Melatonin for Pain and Anxiety After Total Knee Arthroplasty Under Spinal Anesthesia | Mirogabalin | Phase 3 | Not yet recruiting | Beni-Suef University | Nov 20, 2026 |
| Efficacy and Safety of Mirogabalin in Uremic Pruritus | Mirogabalin | Phase 2 | Not yet recruiting | Alexandria University | Nov 13, 2026 |
| Perioperative Mirogabalin for Pain Relief After Modified Radical Mastectomy | Mirogabalin | Not applicable | Not yet recruiting | Cairo University | Oct 19, 2026 |
| Mirogabalin Plus EBMP for IC/BPS | Mirogabalin | Phase 1 | Not yet recruiting | Beijing Tiantan Hospital | Sep 3, 2026 |
| Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain | Mirogabalin | Phase 4 | Recruiting | Bangladesh Medical University | Mar 5, 2026 |
| The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster | Mirogabalin | Not applicable | Recruiting | Beijing Tiantan Hospital | Dec 29, 2025 |
| The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia | Mirogabalin | Not applicable | Recruiting | Beijing Tiantan Hospital | Sep 5, 2025 |
| Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA | Mirogabalin | Not applicable | Recruiting | Thammasat University Hospital | Mar 25, 2024 |
- Cerebellar atrophy, developmental delay, and seizures0.74
- Epilepsy0.70
- Seizure0.60
- Neuropathic pain0.60
- Fibromyalgia0.60
- Restless legs syndrome0.59
- Genetic developmental and epileptic encephalopathy0.58
- Anxiety disorder0.58
- Postherpetic neuralgia0.57
- Neuralgia0.56
- Infantile epileptic encephalopathy0.56
- Focal-onset seizure0.52
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3896, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt Q9NY47, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets